ArticleDiabetologia2026

Beta cell glucose sensitivity identifies clinical response to disease-modifying therapies initiated at stage 3 type 1 diabetes onset.

Carmella Evans-Molina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.